|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-7-26
|
|
pubmed:abstractText |
The distribution of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms was investigated in 80 consecutive breast cancer patients treated with adjuvant chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1877-783X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
490-3
|
|
pubmed:dateRevised |
2011-6-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20371218-Adult,
pubmed-meshheading:20371218-Aged,
pubmed-meshheading:20371218-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20371218-Breast Neoplasms,
pubmed-meshheading:20371218-Carcinoma, Ductal, Breast,
pubmed-meshheading:20371218-Carcinoma, Lobular,
pubmed-meshheading:20371218-Chemotherapy, Adjuvant,
pubmed-meshheading:20371218-Female,
pubmed-meshheading:20371218-Genotype,
pubmed-meshheading:20371218-Humans,
pubmed-meshheading:20371218-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:20371218-Middle Aged,
pubmed-meshheading:20371218-P-Glycoprotein,
pubmed-meshheading:20371218-Polymorphism, Genetic,
pubmed-meshheading:20371218-Prognosis,
pubmed-meshheading:20371218-Thymidylate Synthase,
pubmed-meshheading:20371218-Tumor Suppressor Protein p53
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy.
|
|
pubmed:affiliation |
Clinical Science Department, Universidad de Las Palmas de Gran Canaria, Spain. lhenriquez@dcc.ulpgc.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
